2-溴-4-氟-5'-(三氟甲基)苯胺 | 193090-60-7

• 物质功能分类: 有机原料 - 氨基化合物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-溴-4-氟-5'-(三氟甲基)苯胺
• 中文别名: 5-氨基-4-溴-2-氟三氟甲基苯；2-溴-4-氟-5-三氟甲基苯胺
• 英文名称: 2-bromo-4-fluoro-5-(trifluoromethyl)aniline
• CAS: 193090-60-7
• 化学式: C₇H₄BrF₄N
• 分子量: 258.013
• InChiKey: ZRMRCSMDONHRKT-UHFFFAOYSA-N

物化性质

• 熔点：
  24-29°C
• 沸点：
  253.7±40.0 °C(Predicted)
• 密度：
  1.771±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  避氧化物

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险等级：
  6.1
• 海关编码：
  2921420090
• 包装等级：
  III
• 危险类别：
  6.1
• 危险品运输编号：
  UN2811
• 危险性防范说明：
  P262,P280
• 危险性描述：
  H302,H312,H332
• 储存条件：
  保存方法：密闭、阴凉、通风干燥。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-4-fluoro-5-(trifluoromethyl)aniline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H331: Toxic if inhaled
H302: Harmful if swallowed
H312: Harmful in contact with skin
H315: Causes skin irritation
H319: Causes serious eye irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P304+P340:
P405: Store locked up

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-4-fluoro-5-(trifluoromethyl)aniline
CAS number: 193090-60-7

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H4BrF4N
Molecular weight: 258.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (2-Bromo-4-fluoro-5-(trifluoromethyl)aniline)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-4-氟-5'-(三氟甲基)苯胺 在 甲醇 、 1,1'-双(二苯基膦)二茂铁 、 sodium tetrahydroborate 、 亚硝酸特丁酯 、 二(三甲基铝)-1,4-二氮杂二环[2.2.2]辛烷加合物 、 二氯双[二叔丁基-(4-二甲基氨基苯基)膦]钯(II) 、 palladium diacetate 、 sodium hydride 、 caesium carbonate 、 三乙胺 、 cobalt(II) chloride 、 copper(I) bromide 、 copper(ll) bromide 作用下， 以 四氢呋喃 、 甲醇 、 正己烷 、 水 、 二甲基亚砜 、 N,N-二甲基甲酰胺 、 甲苯 、 乙腈 、 mineral oil 为溶剂， 110.0 ℃ 、344.75 kPa 条件下， 反应 51.0h， 生成 2-[7-fluoro-1-oxo-6-(trifluoromethyl)spiro[3H-isoquinoline-4,1'-cyclopropane]-2-yl]-N-(5-fluoropyrimidin-2-yl)acetamide
  参考文献：
  名称：

  [EN] COMPOUNDS, COMPOSITIONS, AND METHODS
  [FR] COMPOSÉS, COMPOSITIONS ET PROCÉDÉS

  摘要：

  本公开涉及一般与NLR家族Pyrin域含有3（NLRP3）的小分子调节剂有关，或其药学上可接受的盐，同位素富集的类似物，立体异构体，立体异构体混合物或前药，以及其制备方法和中间体，以及使用方法。

  公开号：

  WO2022109268A1
• 作为产物：
  描述：

  4-氟-3-三氟甲基苯胺 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 生成 2-溴-4-氟-5'-(三氟甲基)苯胺
  参考文献：
  名称：

  [EN] COMPOUNDS, COMPOSITIONS, AND METHODS
  [FR] COMPOSÉS, COMPOSITIONS ET PROCÉDÉS

  摘要：

  本公开涉及一般与NLR家族Pyrin域含有3（NLRP3）的小分子调节剂有关，或其药学上可接受的盐，同位素富集的类似物，立体异构体，立体异构体混合物或前药，以及其制备方法和中间体，以及使用方法。

  公开号：

  WO2022109268A1

文献信息

• [EN] SUBSTITUTED TRIAZOLE AND IMIDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS<br/>[FR] DÉRIVÉS DE TRIAZOLE ET D'IMIDAZOLE SUBSTITUÉS EN TANT QUE MODULATEURS DE GAMMA SECRÉTASE
  申请人：ORTHO MCNEIL JANSSEN PHARM

  公开号：WO2011006903A1

  公开（公告）日：2011-01-20

  The present invention is concerned with novel substituted triazole and imidazole derivatives of Formula (I) wherein R1, R2, A1, A2, A3, A4, X, and Het1 have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.

  本发明涉及具有以下式（I）的新型取代三唑和咪唑衍生物，其中R1、R2、A1、A2、A3、A4、X和Het1的含义如权利要求中所定义。根据本发明的化合物可用作γ-分泌酶调节剂。该发明还涉及制备这种新型化合物的方法，包含所述化合物作为活性成分的药物组合物，以及将所述化合物用作药物的用途。
• [EN] ERAP1 MODULATORS<br/>[FR] MODULATEURS ERAP1
  申请人：GREY WOLF THERAPEUTICS LTD

  公开号：WO2021094763A1

  公开（公告）日：2021-05-20

  The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or hydrate thereof, A compound of formula (I), or a pharmaceutically acceptable salt or hydrate thereof, (I) wherein: Z is a group of formula: (II) wherein P and Q are each independently CR12R13; or one of P and Q is NR14 and the other is CR12R13; the group X-Y is -NHSO2- or -SO2NH-; R1 is H, CN or alkyl; R2 is selected from COOH and a tetrazolyl group; R3 is selected from H, Cl and alkyl; R4 is selected from H and halo; R5 is selected from H, alkyl, haloalkyl, SO2-alkyl, Cl, alkoxy, OH, CN, hydroxyalkyl, alkylthio, heteroaryl, cycloalkyl, heterocycloalkyl and haloalkoxy; R6 is H; R7 is selected from H, CN, haloalkyl, halo, SO2-alkyl, heteroaryl, SO2NR16R17, CONR10R11 and alkyl, wherein said heteroaryl group is optionally substituted by one or more substituents selected from alkyl, halo, alkoxy, CN, haloalkyl and OH; R8 is selected from H, alkyl, haloalkyl and halo; R9 is H or halo; and R10, R11, R12, R13, R14, R16 and R17 are each independently H or alkyl; R15 is selected from alkyl, halo, alkoxy, CN, haloalkyl and OH; and m and n are each independently 0, 1, 2 or 3. Further aspects of the invention relate to such compounds for use in the field of immune-oncology and related applications.

  本发明涉及一种具有以下结构的化合物（I）或其药用可接受的盐或水合物，其中：Z是以下结构的基团（II），其中P和Q分别独立地为CR12R13；或者P和Q中的一个为NR14，另一个为CR12R13；基团X-Y为-NHSO2-或-SO2NH-；R1为H，CN或烷基；R2选自COOH和四氮唑基团；R3选自H、Cl和烷基；R4选自H和卤素；R5选自H、烷基、卤代烷基、SO2-烷基、Cl、烷氧基、OH、CN、羟基烷基、烷基硫醚、杂环芳基、环烷基、杂环烷基和卤代烷氧基；R6为H；R7选自H、CN、卤代烷基、卤素、SO2-烷基、杂环芳基、SO2NR16R17、CONR10R11和烷基，其中所述的杂环芳基可以选择地由一种或多种取代基选自烷基、卤素、烷氧基、CN、卤代烷基和羟基取代；R8选自H、烷基、卤代烷基和卤素；R9为H或卤素；R10、R11、R12、R13、R14、R16和R17各自独立地为H或烷基；R15选自烷基、卤素、烷氧基、CN、卤代烷基和羟基；m和n各自独立地为0、1、2或3。该发明的进一步方面涉及这些化合物在免疫肿瘤学领域及相关应用中的使用。
• [EN] COMPOUNDS FOR BINDING AND IMAGING AMYLOID PLAQUES AND THEIR USE<br/>[FR] COMPOSÉS DESTINÉS À LA LIAISON ET À L'IMAGERIE DE PLAQUES AMYLOÏDES ET LEUR UTILISATION
  申请人：BAYER PHARMA AG

  公开号：WO2012007510A1

  公开（公告）日：2012-01-19

  The present invention relates to novel compounds (benzothiazolopyrazoles and thiazolopyridin-pyrazoles) useful for binding and imaging amyloid deposits and their use in detecting or treating Alzheimer's disease and amyloidosis.

  本发明涉及新型化合物（苯并噻唑吡唑和噻唑吡啶-吡唑）用于结合和成像淀粉样沉积物，并用于检测或治疗阿尔茨海默病和淀粉样病的用途。
• Palladium‐Catalyzed Regioselective <i>peri</i>‐ and <i>ortho</i>‐Halogenation of 1‐Naphthaldehydes: Application to the Synthesis of Polycyclic Natural Product Skeletons
  作者：Hugo Amistadi‐Revol、Julian Garrec、Nicolas Casaretto、Sébastien Prévost

  DOI：10.1002/ejoc.202300359

  日期：2023.6.21

  an imine formation was necessary to achieve C2-halogenation. The mechanism as well as the regioselectivity of the reaction were studied and the halogenated products were used in the synthesis of natural product skeletons.

  公开了钯催化的1-萘醛的区域选择性卤化反应。当使用醛作为导向基团时，观察到C8-选择性，而亚胺的形成是实现C2-卤化所必需的。研究了该反应的机理和区域选择性，并将卤化产物用于天然产物骨架的合成。
• Ruthenium-Catalyzed C–H Arylation of Aromatic Acids with <i>ortho</i>-Haloaniline To Access Phenanthridinones
  作者：Xianglin Luo、Jiayi Shen、Huanfeng Jiang、Liangbin Huang

  DOI：10.1021/acs.orglett.3c04377

  日期：2024.4.12

  material science; thus, it is highly desirable to develop an efficient and robust method to construct phenanthridinone from readily available starting materials. Herein, we report a Ru-catalyzed C–H arylation of aromatic carboxylic acids with ortho-haloanilines, followed by intramolecular dehydration to afford phenanthridinones in high yields.

  菲啶酮是制药和材料科学中的一个重要部分；因此，非常需要开发一种有效且稳健的方法来从容易获得的起始材料构建菲啶酮。在此，我们报道了一种钌催化的芳香族羧酸与邻卤代苯胺的C-H芳基化反应，然后进行分子内脱水，以高产率得到菲啶酮。